First Time Loading...
A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.72 EUR -7.69% Market Closed
Updated: Jun 1, 2024

Acticor Biotech SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Acticor Biotech SA
Revenue Peer Comparison

Comparables:
VLA
NANO
IPH
G
GNFT
ABVX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Revenue
€224.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanobiotix SA
PAR:NANO
Revenue
€30.1m
CAGR 3-Years
744%
CAGR 5-Years
204%
CAGR 10-Years
67%
Innate Pharma SA
PAR:IPH
Revenue
€51.9m
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
15%
G
Genfit SA
PAR:GNFT
Revenue
€38.2m
CAGR 3-Years
70%
CAGR 5-Years
38%
CAGR 10-Years
20%
Abivax SA
PAR:ABVX
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Revenue?
Revenue
0 EUR

Based on the financial report for Jun 30, 2023, Acticor Biotech SA's Revenue amounts to 0 EUR.